Principal Financial Officer · Myovant Sciences Ltd. (MYOV)

Uneek Mehra

FY2021 is the first fiscal year CompBrief holds for Uneek Mehra as a named executive officer of Myovant Sciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$5,164,872

Salary $278,609Stock awards $2,249,996Bonus $200,000

2nd of 4 named executive officers at Myovant Sciences by FY2021 total.

4 named officers on file for Myovant Sciences, FY2021

Uneek Mehra’s pay file — $29

  • 1 fiscal year of pay, line by line
  • MYOV’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Myovant Sciences’s whole pay program stands against its peers

  • Myovant Sciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MYOV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed July 28, 2022 (DEF 14A).

Free

Get Uneek Mehra’s full pay file as a PDF — free

More than this page: up to 10 years of Uneek’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Uneek Mehra compensation by year

Myovant Sciences Summary Compensation Table · the one fiscal year held
In US dollars, as Myovant Sciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$278,609
Bonus$200,000
Stock awards$2,249,996
Option awards$2,283,515
Non-equity incentive$142,000
Pension and deferred compensation$0
All other$10,752
Total$5,164,872

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Myovant Sciences Ltd. DEF 14A filed July 28, 2022, accession 0001140361-22-027161, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Myovant Sciences Ltd. filed document, accession 0001140361-22-027161. Every figure is read from that document and cited to the page and table it appears in. Filed July 28, 2022.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU103,069$1,372,879—
Option165,192—$21.83

Per the Outstanding Equity Awards at Fiscal Year-End table in Myovant Sciences Ltd.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Myovant Sciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
David MarekPrincipal Executive Officer$6,247,509
Uneek Mehra · this pagePrincipal Financial Officer$5,164,872
Frank KarbeFormer Principal Financial and Accounting Officer$4,451,137
Lauren MerendinoChief Commercial Officer$3,463,677

The full Myovant Sciences compensation record

free company brief

This page is one person within Myovant Sciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Myovant Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Uneek Mehra's compensation dossier · One-time report. No refunds.